Abstract:Recently, molecular generation models based on deep learning have attracted significant attention in drug discovery. However, most existing molecular generation models have serious limitations in the context of drug design wherein they do not sufficiently consider the effect of the three-dimensional (3D) structure of the target protein in the generation process. In this study, we developed a new deep learning-based molecular generator, SBMolGen, that integrates a recurrent neural network, a Monte Carlo tree search, and docking simulations. The results of an evaluation using four target proteins (two kinases and two G protein-coupled receptors) showed that the generated molecules had a better binding affinity score (docking score) than the known active compounds, and the generated molecules possessed a broader chemical space distribution. SBMolGen not only generates novel binding active molecules but also presents 3D docking poses with target proteins, which will be useful in subsequent drug design. The code is available at <a class="extLink" href="https://github.com/clinfo/SBMolGen">https://github.com/clinfo/SBMolGen</a>.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.1c00679?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.1c00679</a>.Number of generated molecules, example of generated molecules for target EGFR at C = 1.0, example of generated molecules for target AA2AR at C = 1.0, example of generated molecules for target ADRB2 at C = 1.0; distribution of the similarity score of the generated molecules and distribution of the scaffold similarity score of the generated molecules; distribution of the SA scores of the generated molecules; distributions of the QED scores of the generated molecules; plots of IFIE<sub>sum</sub> against experimentally determined Δ<i>G</i> for (A) nine CDK2 inhibitors and (B) generated molecules; distribution of the docking scores of the generated molecules against DDR1; chemical structures of nine CDK2 inhibitors and their properties (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.1c00679/suppl_file/ci1c00679_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Molecular generation strategy and optimization based on A2C reinforcement learning in de novo drug design

De novo drug design by iterative multiobjective deep reinforcement learning with graph-based molecular quality assessment

Comprehensive assessment of deep generative architectures for de novo drug design

Electron-density informed effective and reliable de novo molecular design and lead optimization with ED2Mol

Deep Lead Optimization: Leveraging Generative AI for Structural Modification

De novo generation of dual-target ligands using adversarial training and reinforcement learning

Optimizing blood-brain barrier permeation through deep reinforcement learning for de novo drug design

<i>De novo</i> generation of dual-target ligands using adversarial training and reinforcement learning

Widely Used and Fast De Novo Drug Design by a Protein Sequence-Based Reinforcement Learning Model

Generation of Rational Drug-Like Molecular Structures Through a Multiple-Objective Reinforcement Learning Framework

Status and Prospects of Research on Deep Learning-based De Novo Generation of Drug Molecules

A Transformer-based Generative Model for De Novo Molecular Design

De Novo Drug Design by Multi-Objective Path Consistency Learning with Beam A∗ Search

Multi-objective molecular generation via clustered Pareto-based reinforcement learning

Diversity oriented Deep Reinforcement Learning for targeted molecule generation

Utilizing reinforcement learning for de novo drug design

Deep Generative Models in De Novo Drug Molecule Generation

Structure-Based de Novo Molecular Generator Combined with Artificial Intelligence and Docking Simulations

Multi-Objective De Novo Drug Design with Conditional Graph Generative Model

De Novo Drug Design Using Transformer-Based Machine Translation and Reinforcement Learning of an Adaptive Monte Carlo Tree Search

AlphaDrug: Protein Target Specific De Novo Molecular Generation